Allocation of Essential Use Allowances for Calendar Year 2010
- In accordance with the Montreal Protocol on Substances that Deplete the Ozone Layer and the Clean Air Act, EPA is
allocating essential use allowances to permit U.S. companies to obtain limited quantities of certain ozone-depleting substances (ODSs) that have been phased out of production.
- This action proposes an allocation of essential use allowances for chlorofluorocarbons (CFCs) to
a U.S. pharmaceutical company for the manufacture of metered-dose inhalers (MDIs) for the treatment of asthma and chronic obstructive pulmonary disease.
- The allocations are based on the Food and Drug Administration’s (FDA) determination
that 30.0 metric tons of CFCs are necessary for use in MDIs for 2010.
- Essential use allowances enable a person to obtain a controlled Class I
ODS under an exemption to the regulatory ban on the production and import of
- Under the Montreal Protocol, exemptions may be granted for uses that are
determined by the Parties to be "essential." Decision IV/25, taken by the
Parties to the Protocol in 1992, established criteria for determining whether
a specific use should be approved as essential, and set forth the
international process for making determinations of essentiality.
- EPA allocates essential use allowances for exempted production or import of a specific quantity of a class I ODS solely for the designated essential purpose.
For Further Information
- For more information about this action, please email
of EPA’s Office of Atmospheric Programs
or contact by phone at (202) 343-9055.
to EPA's page on essential use of CFCs for metered dose inhalers.